Following COVID-19, Accenture and a crew of businesses crafted answers to assist Dallas County Well being and Human Products and services (DCHHS) make sure long-term preparedness to handle long run public well being demanding situations.
Rachel Oldham, supervisor at Accenture, will speak about what the crew has been operating on to handle DCHHS’s wishes in a consultation at HIMSS World Convention & Exhibition in Orlando subsequent week entitled “Dallas County Public Well being Illness Surveillance and Investigation Device.”
Oldham shared highlights of the approaching consultation with MobiHealthNews and what Oldham and her fellow panelists hope attendees will remove from the dialogue.
MobiHealthNews: Are you able to let us know about your HIMSS24 upcoming consultation and what you’ll speak about?
Rachel Oldham: We can be copresenting with the director of Dallas County Well being and Human Products and services (DCHHS), Dr. Huang, at the illness modernization efforts that the blended crew has been operating on over the past 3.5 years.
The primary part of the dialog can be Dr. Huang masking the challenge’s background, highest practices and the answer review at a prime degree.
I will then take the target audience via a platform demo highlighting one of the most main options that Accenture constructed out in response to DCHHS goals. A few of the ones options we will be taking a look at come with spaces the place we diminished handbook efforts, speaking via one of the most integrations which were arrange, explaining information governance actions that happen and the way we offer investigators a 360-degree view of affected person knowledge.
We’re going to end up the dialog by way of masking the results and enhancements those efforts have had on DCHHS, in addition to public well being affect. With any time final, we are hoping to reply to questions and open the dialog as much as alternatives for collaboration and concepts for growth.
MHN: What is exclusive about Dallas County’s Surveillance Device? Does it assist the private and non-private healthcare sectors?
Oldham: Dallas County’s Surveillance Device is a exceptional answer constructed to take care of over 2.6 million citizens, higher than some states.
With the management of Dr. Huang, Dallas County operating with Accenture, has been in a position to do issues that many different native jurisdictions or even states have no longer had the power to do.
The gadget is in a position to function a complete gadget that integrates more than one public well being and social services and products information in combination, breaking down other information silos. It bureaucracy a supply of reality that investigators are in a position to leverage to concentrate on how they may be able to higher cope with the general public well being factor somewhat than spending the time on handbook steps to ingest, prepare, cleanse and file the tips.
The gadget these days helps public well being, with the crew taking a look into a lot of pilots to reinforce interoperability with healthcare supplier services and products, reminiscent of adopting Rapid Healthcare Interoperability Assets (FHIR) based totally change and/or Depended on Trade Framework and Commonplace Settlement (TEFCA) at some point.
MHN: What do you hope attendees be informed out of your consultation?
Oldham: Collaboration has been key for each the Accenture and DCHHS groups in this illness modernization challenge. The objective is to have a mutually advisable presentation and dialog on those efforts, as it’s one thing that all of the business is dealing with.
Because the presenters, we are hoping to achieve treasured insights from the attendees on issues they have got noticed of their reporting and daily processes that may assist higher our answer.
From the attendees’ viewpoint, we are hoping our consultation sparks some concepts of ways they may be able to beef up their workflows, exhibit other collaboration alternatives and doubtlessly achieve answer concepts for the longer term.
“Dallas County Public Well being Illness Surveillance and Investigation Device” is scheduled for Wednesday, March 13, 10:00 a.m.-11:00 a.m. ET, in W308A at HIMSS24 in Orlando. Be informed extra and sign up.